160 related articles for article (PubMed ID: 38051378)
1. Enhanced therapeutic efficacy of doxorubicin/cyclophosphamide in combination with pitavastatin or simvastatin against breast cancer cells.
Dewidar SA; Hamdy O; Soliman MM; El Gayar AM; El-Mesery M
Med Oncol; 2023 Dec; 41(1):7. PubMed ID: 38051378
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanism underlying the anticancer effect of simvastatin on MDA-MB-231 human breast cancer cells.
Shen YY; Yuan Y; Du YY; Pan YY
Mol Med Rep; 2015 Jul; 12(1):623-30. PubMed ID: 25738368
[TBL] [Abstract][Full Text] [Related]
3. Regulation of BAX and BCL-2 expression in breast cancer cells by chemotherapy.
Gibson LF; Fortney J; Magro G; Ericson SG; Lynch JP; Landreth KS
Breast Cancer Res Treat; 1999 May; 55(2):107-17. PubMed ID: 10481938
[TBL] [Abstract][Full Text] [Related]
4. Statins inhibit proliferation and induce apoptosis in triple-negative breast cancer cells.
O'Grady S; Crown J; Duffy MJ
Med Oncol; 2022 Jul; 39(10):142. PubMed ID: 35834073
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxicity of Simvastatin in Human Breast Cancer MCF-7 and MDA-MB-231 Cell Lines.
Rezano A; Ridhayanti F; Rangkuti AR; Gunawan T; Winarno GNA; Wijaya I
Asian Pac J Cancer Prev; 2021 Feb; 22(S1):33-42. PubMed ID: 33576210
[TBL] [Abstract][Full Text] [Related]
6. Simvastatin inhibits cancer cell growth by inducing apoptosis correlated to activation of Bax and down-regulation of BCL-2 gene expression.
Spampanato C; De Maria S; Sarnataro M; Giordano E; Zanfardino M; Baiano S; Cartenì M; Morelli F
Int J Oncol; 2012 Apr; 40(4):935-41. PubMed ID: 22134829
[TBL] [Abstract][Full Text] [Related]
7. Bcl-2/bcl-xL bispecific antisense treatment sensitizes breast carcinoma cells to doxorubicin, paclitaxel and cyclophosphamide.
Simões-Wüst AP; Schürpf T; Hall J; Stahel RA; Zangemeister-Wittke U
Breast Cancer Res Treat; 2002 Nov; 76(2):157-66. PubMed ID: 12452453
[TBL] [Abstract][Full Text] [Related]
8. Simvastatin Strongly Augments Proapoptotic, Anti-inflammatory and Cytotoxic Activity of Oxicam Derivatives in Doxorubicin-resistant Colon Cancer Cells.
Środa-Pomianek K; Michalak K; Palko-Łabuz A; Uryga A; Szczęśniak-Sięga B; Wesołowska O
Anticancer Res; 2019 Feb; 39(2):727-734. PubMed ID: 30711951
[TBL] [Abstract][Full Text] [Related]
9. The Combined Use of Phenothiazines and Statins Strongly Affects Doxorubicin-Resistance, Apoptosis, and Cox-2 Activity in Colon Cancer Cells.
Środa-Pomianek K; Michalak K; Palko-Łabuz A; Uryga A; Świątek P; Majkowski M; Wesołowska O
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30813251
[TBL] [Abstract][Full Text] [Related]
10. Simvastatin induces caspase-dependent apoptosis and activates P53 in OCM-1 cells.
Wang Y; Xu SL; Wu YZ; Zhao MS; Xu WJ; Yang HY; Li YX
Exp Eye Res; 2013 Aug; 113():128-34. PubMed ID: 23727160
[TBL] [Abstract][Full Text] [Related]
11. Centaurea cyanus extracted 13-O-acetylsolstitialin A decrease Bax/Bcl-2 ratio and expression of cyclin D1/Cdk-4 to induce apoptosis and cell cycle arrest in MCF-7 and MDA-MB-231 breast cancer cell lines.
Keyvanloo Shahrestanaki M; Bagheri M; Ghanadian M; Aghaei M; Jafari SM
J Cell Biochem; 2019 Oct; 120(10):18309-18319. PubMed ID: 31161672
[TBL] [Abstract][Full Text] [Related]
12. Induction of P3NS1 Myeloma Cell Death and Cell Cycle Arrest by Simvastatin and/or γ-Radiation.
Abdelrahman IY; Helwa R; Elkashef H; Hassan NH
Asian Pac J Cancer Prev; 2015; 16(16):7103-10. PubMed ID: 26514497
[TBL] [Abstract][Full Text] [Related]
13. The nuclear transcription factor kappaB/bcl-2 pathway correlates with pathologic complete response to doxorubicin-based neoadjuvant chemotherapy in human breast cancer.
Buchholz TA; Garg AK; Chakravarti N; Aggarwal BB; Esteva FJ; Kuerer HM; Singletary SE; Hortobagyi GN; Pusztai L; Cristofanilli M; Sahin AA
Clin Cancer Res; 2005 Dec; 11(23):8398-402. PubMed ID: 16322301
[TBL] [Abstract][Full Text] [Related]
14. Simvastatin inhibits proliferation and induces apoptosis in human lung cancer cells.
Yu X; Pan Y; Ma H; Li W
Oncol Res; 2013; 20(8):351-7. PubMed ID: 23924855
[TBL] [Abstract][Full Text] [Related]
15. Simvastatin induces apoptosis of nasopharyngeal carcinoma cells through NF-κB signaling pathway.
Sun FR; Wang SL; Wang M; Sun LM
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6726-6734. PubMed ID: 32633363
[TBL] [Abstract][Full Text] [Related]
16. The role of HMGCR expression in combination therapy of simvastatin and FAC treated locally advanced breast cancer patients.
Yulian ED; Siregar NC; Sudijono B; Hwei LRY
Breast Dis; 2023; 42(1):73-83. PubMed ID: 36938720
[TBL] [Abstract][Full Text] [Related]
17. Comparative Study of Lipophilic Statin Activity in 2D and 3D in vitro Models of Human Breast Cancer Cell Lines MDA-MB-231 and MCF-7.
Bytautaite M; Petrikaite V
Onco Targets Ther; 2020; 13():13201-13209. PubMed ID: 33380809
[TBL] [Abstract][Full Text] [Related]
18. Integration of Ca
Abdoul-Azize S; Buquet C; Li H; Picquenot JM; Vannier JP
Oncogene; 2018 Sep; 37(36):4979-4993. PubMed ID: 29795329
[TBL] [Abstract][Full Text] [Related]
19. Simvastatin induces apoptosis in human breast cancer cells: p53 and estrogen receptor independent pathway requiring signalling through JNK.
Koyuturk M; Ersoz M; Altiok N
Cancer Lett; 2007 Jun; 250(2):220-8. PubMed ID: 17125918
[TBL] [Abstract][Full Text] [Related]
20. Involvement of Chk1-Cdc25A-cyclin A/CDK2 pathway in simvastatin induced S-phase cell cycle arrest and apoptosis in multiple myeloma cells.
Tu YS; Kang XL; Zhou JG; Lv XF; Tang YB; Guan YY
Eur J Pharmacol; 2011 Nov; 670(2-3):356-64. PubMed ID: 21958871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
